v3.26.1
ACQUISITIONS - Schedule of Total Consideration Transferred for the Acquisition (Details) - Amicus Therapeutics - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 27, 2026
Jun. 30, 2026
Jun. 30, 2026
Business Combination [Line Items]      
Cash paid to Amicus' shareholders $ 4,563,463    
Cash settlement towards Amicus’ RSUs and PSUs 142,636    
Cash settlement towards pre-combination portion of stock options 62,946    
Transaction expenses settled by the Company on behalf of Amicus 121,596    
Amicus debt repayment by the Company on behalf of Amicus 432,920    
Total consideration 5,323,561    
Cash settlement on vested stock option 51,900    
Cash settlement on unvested stock option $ 11,000    
Fair value of nonvested stock options   $ 13,000 $ 13,000